M. Burnouf-Radosevich

Nanofiltration, a New Specific Virus Elimination Method Applied to High‐Purity Factor IX and Factor XI Concentrates

J. Huart, T. Burnouf, M. Burnouf-Radosevich, 1994, Vox sanguinis.

Chromatographic Preparation of a Therapeutic Highly Purified von Willebrand Factor Concentrate from Human Cryoprecipitate

T. Burnouf, M. Burnouf-Radosevich, 1992, Vox sanguinis.

A Highly Purified Factor VIII:c Concentrate Prepared from Cryoprecipitate by Ion‐Exchange Chromatography

J. Huart, M. Goudemand, T. Burnouf, 1991, Vox Sanguinis.

α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura

P. Mannucci, A. Benigni, P. Ruggenenti, 1995, The Lancet.

A therapeutic, highly purified factor XI concentrate from human plasma

T. Burnouf, M. Burnouf-Radosevich, 1992, Transfusion.

Biochemical and Physical Properties of a Solvent‐Detergent‐Treated Fibrin Glue

J. Huart, T. Burnouf, M. Burnouf-Radosevich, 1990, Vox sanguinis.

Strategy of Virus Removal / Inactivation of Plasma-Derived Products : Interest of Nanofiltration as a New Virus Elimination Method

T. Burnouf, M. Burnouf-Radosevich, 1994 .

Large-scale preparation of highly purified human C1-inhibitor for therapeutic use.

T. Burnouf, M. Poulle, M. Burnouf-Radosevich, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A pasteurized therapeutic plasma.

J. Huart, T. Burnouf, M. Burnouf-Radosevich, 1992, Infusionstherapie und Transfusionsmedizin.

alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpura.

G. Remuzzi, P. Mannucci, A. Benigni, 1995, Lancet.

Von Willebrand factor purification from human plasma cryoprecipitate

M. Burnouf-Radosevich, 1994 .